These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 9607557

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Hepatocyte growth factor as mitogen, motogen and morphogen, and its roles in organ regeneration.
    Nakamura T.
    Princess Takamatsu Symp; 1994; 24():195-213. PubMed ID: 8983076
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Hepatocyte growth factor/scatter factor (HGF/SF) is produced by human bone marrow stromal cells and promotes proliferation, adhesion and survival of human hematopoietic progenitor cells (CD34+).
    Weimar IS, Miranda N, Muller EJ, Hekman A, Kerst JM, de Gast GC, Gerritsen WR.
    Exp Hematol; 1998 Aug; 26(9):885-94. PubMed ID: 9694510
    [Abstract] [Full Text] [Related]

  • 26. Normal and malignant prostate epithelial cells differ in their response to hepatocyte growth factor/scatter factor.
    Gmyrek GA, Walburg M, Webb CP, Yu HM, You X, Vaughan ED, Vande Woude GF, Knudsen BS.
    Am J Pathol; 2001 Aug; 159(2):579-90. PubMed ID: 11485916
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Requirement of regulated activation of Ras for response of MDCK cells to hepatocyte growth factor/scatter factor.
    Terauchi R, Kitamura N.
    Exp Cell Res; 2000 May 01; 256(2):411-22. PubMed ID: 10772814
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases.
    Qian F, Engst S, Yamaguchi K, Yu P, Won KA, Mock L, Lou T, Tan J, Li C, Tam D, Lougheed J, Yakes FM, Bentzien F, Xu W, Zaks T, Wooster R, Greshock J, Joly AH.
    Cancer Res; 2009 Oct 15; 69(20):8009-16. PubMed ID: 19808973
    [Abstract] [Full Text] [Related]

  • 32. A novel recombinant soluble splice variant of Met is a potent antagonist of the hepatocyte growth factor/scatter factor-Met pathway.
    Tiran Z, Oren A, Hermesh C, Rotman G, Levine Z, Amitai H, Handelsman T, Beiman M, Chen A, Landesman-Milo D, Dassa L, Peres Y, Koifman C, Glezer S, Vidal-Finkelstein R, Bahat K, Pergam T, Israel C, Horev J, Tsarfaty I, Ayalon-Soffer M.
    Clin Cancer Res; 2008 Jul 15; 14(14):4612-21. PubMed ID: 18628476
    [Abstract] [Full Text] [Related]

  • 33. Hepatocyte growth Factor/Scatter factor (HGF/SF) is a regulator of fibronectin splicing in MDCK cells: comparison between the effects of HGF/SF and TGF-beta1 on fibronectin splicing at the EDA region.
    Inoue T, Nabeshima K, Shimao Y, Koono M.
    Biochem Biophys Res Commun; 1999 Jun 24; 260(1):225-31. PubMed ID: 10381371
    [Abstract] [Full Text] [Related]

  • 34. Hepatocyte growth factor induces tubulogenesis of primary renal proximal tubular epithelial cells.
    Bowes RC, Lightfoot RT, Van De Water B, Stevens JL.
    J Cell Physiol; 1999 Jul 24; 180(1):81-90. PubMed ID: 10362020
    [Abstract] [Full Text] [Related]

  • 35. Membrane-associated HB-EGF modulates HGF-induced cellular responses in MDCK cells.
    Singh AB, Tsukada T, Zent R, Harris RC.
    J Cell Sci; 2004 Mar 15; 117(Pt 8):1365-79. PubMed ID: 14996914
    [Abstract] [Full Text] [Related]

  • 36. Transfection of human hepatocyte growth factor gene ameliorates secondary lymphedema via promotion of lymphangiogenesis.
    Saito Y, Nakagami H, Morishita R, Takami Y, Kikuchi Y, Hayashi H, Nishikawa T, Tamai K, Azuma N, Sasajima T, Kaneda Y.
    Circulation; 2006 Sep 12; 114(11):1177-84. PubMed ID: 16952986
    [Abstract] [Full Text] [Related]

  • 37. met and HGF-SF in normal melanocytes and melanoma cells.
    Halaban R, Rubin JS, White W.
    EXS; 1993 Sep 12; 65():329-39. PubMed ID: 8380740
    [Abstract] [Full Text] [Related]

  • 38. Transforming growth factor beta2 inhibition of hepatocyte growth factor-induced endothelial proliferation and migration.
    Manganini M, Maier JA.
    Oncogene; 2000 Jan 06; 19(1):124-33. PubMed ID: 10644987
    [Abstract] [Full Text] [Related]

  • 39. Hepatocyte growth factor/scatter factor activates proliferation in melanoma cells through p38 MAPK, ATF-2 and cyclin D1.
    Recio JA, Merlino G.
    Oncogene; 2002 Feb 07; 21(7):1000-8. PubMed ID: 11850817
    [Abstract] [Full Text] [Related]

  • 40. Scatter factor (hepatocyte growth factor) is a potent angiogenesis factor in vivo.
    Rosen EM, Grant DS, Kleinman HK, Goldberg ID, Bhargava MM, Nickoloff BJ, Kinsella JL, Polverini P.
    Symp Soc Exp Biol; 1993 Feb 07; 47():227-34. PubMed ID: 8165567
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.